Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A clinical pharmacist survey of prophylactic strategies used to prevent adverse events of lipid-associated formulations of amphotericin B.

Literature DB >> 30773080

A clinical pharmacist survey of prophylactic strategies used to prevent adverse events of lipid-associated formulations of amphotericin B.

Daniel B Chastain¹, Rachele L Giles², Christopher M Bland³, Carlos Franco-Paredes^4,5, Andrés F Henao-Martínez⁴, Henry N Young⁶.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2019 PMID： 30773080 PMCID： PMC6482081 DOI： 10.1080/23744235.2019.1568546

Source DB: PubMed Journal: Infect Dis (Lond) ISSN： 2374-4243

× No keyword cloud information.

10 in total

1. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.

Authors: J Szebeni; J L Fontana; N M Wassef; P D Mongan; D S Morse; D E Dobbins; G L Stahl; R Bünger; C R Alving
Journal: Circulation Date: 1999-05-04 Impact factor: 29.690

2. Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics.

Authors: Maureen M Roden; Lucienne D Nelson; Tena A Knudsen; Paul F Jarosinski; Judith M Starling; Stacey E Shiflett; Karim Calis; Robert DeChristoforo; Gerald R Donowitz; Donald Buell; Thomas J Walsh
Journal: Clin Infect Dis Date: 2003-05-08 Impact factor: 9.079

Review 3. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis.

Authors: Sóstenes Mistro; Isis de M Maciel; Rouseli G de Menezes; Zuinara P Maia; Robert T Schooley; Roberto Badaró
Journal: Clin Infect Dis Date: 2012-04-05 Impact factor: 9.079

Review 4. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis.

Authors: S B Girois; F Chapuis; E Decullier; B G P Revol
Journal: Eur J Clin Microbiol Infect Dis Date: 2006-02 Impact factor: 3.267

5. Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis.

Authors: Shan-Shan Li; Xin-Yue Tang; Sheng-Guo Zhang; Shun-Lan Ni; Nai-Bin Yang; Ming-Qin Lu
Journal: Infect Dis (Lond) Date: 2016-04-04

6. Pretreatment regimens for adverse events related to infusion of amphotericin B.

Authors: S D Goodwin; J D Cleary; C A Walawander; J W Taylor; T H Grasela
Journal: Clin Infect Dis Date: 1995-04 Impact factor: 9.079

Review 7. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.

Authors: R A Branch
Journal: Arch Intern Med Date: 1988-11

8. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.

Authors: Diego R Falci; Franciane B da Rosa; Alessandro C Pasqualotto
Journal: Mycoses Date: 2015-01-15 Impact factor: 4.377

9. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.

Authors: J R Wingard; M H White; E Anaissie; J Raffalli; J Goodman; A Arrieta
Journal: Clin Infect Dis Date: 2000-11-07 Impact factor: 9.079

10. Distribution and activity of amphotericin B in humans.

Authors: K J Christiansen; E M Bernard; J W Gold; D Armstrong
Journal: J Infect Dis Date: 1985-11 Impact factor: 5.226